Organization · Venture Capital
Global BioAccess Fund
Global BioAccess Fund is an investment firm based in New York, focusing on early-stage biopharmaceutical companies. It invests in transformative technologies addressing unmet medical needs in various therapeutic areas.
Overview
What Global BioAccess Fund does
What Global BioAccess Fund is
Global BioAccess Fund is an investment firm based in New York, focusing on early-stage biopharmaceutical companies. It invests in transformative technologies addressing unmet medical needs in various therapeutic areas.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find Global BioAccess Fund elsewhere
Open the official website or a supported primary organization account.
Capability profile
Global BioAccess Fund as a funder
Investment thesis
The Global BioAccess Fund partners with early-stage biopharmaceutical companies to invest in transformative technologies that address unmet medical needs.
Focus narrative
The Global BioAccess Fund primarily invests in early-stage companies from Series A to Series C rounds, with a focus on transformative technologies in the biopharmaceutical sector. The fund typically invests up to $10 million throughout a company's lifespan, emphasizing partnerships with companies that are addressing critical medical needs, particularly in the United States, but also considering opportunities globally.
Value beyond capital
The Global BioAccess Fund adds value to its portfolio companies by providing not only capital but also strategic guidance and industry expertise. The team, comprised of experienced professionals in the biopharmaceutical sector, works closely with founders to navigate challenges, refine business strategies, and accelerate growth, ultimately aiming to enhance the impact of their innovations in healthcare.
Terms and economics
- Typical check
- $1,000,000–$10,000,000
Focus and fit
- Stages
- Series A · Series B · Series C
- Regions
- Global · United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 9
Portfolio context
Notable portfolio companies include: Epsilogen: Develops immunoglobulin E (IgE) antibodies for cancer treatment. Website VITTORIA Biotherapeutics: Focuses on CD5 as a novel checkpoint for cell therapies. Website Cartography Biosciences: Pioneers methods to map cancer antigens for targeted therapies. Website Acesion Pharma: Develops an antiarrhythmic drug targeting SK channels for atrial fibrillation. Website SHIRATRONICS: Aims to transform the lives of individuals with chronic migraines. Website Ensho Therapeutics: Focuses on breakthrough oral therapies for inflammatory bowel disease. Website Odyssey Therapeutics: Creates precision medicines for cancer and inflammatory diseases. Website Nuvig Therapeutics: Developing an immunomodulator for autoimmune diseases. Website Alveus Therapeutics: Develops next-generation therapies for obesity and metabolic diseases. Website
Common questions
What to know about Global BioAccess Fund
Upseed classifies Global BioAccess Fund under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.